Kymera Therapeutics Reports Positive Phase 1 Results for KT-579
Kymera Therapeutics reported positive results from a Phase 1 trial of KT-579 in healthy volunteers.
Story updates
11:32:10 AM UTC
SquawkNews
KT-579 showed positive Phase 1 results in healthy volunteers, supporting continued development of th